Northwest Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.057; its P/E ratio is -9.04; Northwest Biotherapeutics is scheduled to report earnings on May 16, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 445.00K	$ 406.00K	$ 201.00K	$ 36.00K	$ 597.00K
Gross Profit	$ 445.00K	$ 406.00K	$ 201.00K	$ 36.00K	$ 72.00K
EBIT	$ -17.68M	$ -16.91M	$ -13.15M	$ -9.63M	$ -31.33M
EBITDA	$ -17.46M	$ -16.42M	$ -12.66M	$ -9.29M	$ -31.01M
Net Income Common Stockholders	$ -19.26M	$ -19.10M	$ -13.93M	$ -11.05M	$ -32.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.13M	$ 6.10M	$ 1.42M	$ 6.19M	$ 6.96M
Total Assets	$ 27.86M	$ 31.49M	$ 28.44M	$ 32.87M	$ 31.32M
Total Debt	$ 32.79M	$ 27.19M	$ 30.76M	$ 31.36M	$ 26.25M
Net Debt	$ 30.66M	$ 21.09M	$ 29.33M	$ 25.17M	$ 19.29M
Total Liabilities	$ 74.92M	$ 68.94M	$ 89.47M	$ 65.10M	$ 136.37M
Stockholders Equity	$ -65.77M	$ -65.12M	$ -61.03M	$ -55.98M	$ -128.10M
Cash Flow	-
Free Cash Flow	$ -17.38M	$ -14.36M	$ -12.77M	$ -12.57M	$ -11.01M
Operating Cash Flow	$ -16.96M	$ -13.92M	$ -11.52M	$ -11.24M	$ -8.85M
Investing Cash Flow	$ -418.00K	$ -437.00K	$ -1.25M	$ -1.33M	$ -2.16M
Financing Cash Flow	$ 14.41M	$ 17.12M	$ 8.64M	$ 12.58M	$ 11.35M

Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Income Statement >

Northwest Biotherapeutics Debt to Assets

Balance Sheet >

Northwest Biotherapeutics Cash Flow

Cash Flow >

Northwest Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing